The EU-ROP registry revolutionizes retinopathy of prematurity management, offering insights into treatment variations and outcomes across Europe.
Matt Hoffman
Advertisement
Matt Hoffman is the editorial director for Ophthalmology Times, Modern Retina, and Ophthalmology Times Europe. He has covered medical news for MJH Life Sciences, Eye Care Network’s parent company, since 2017.
Articles by Matt Hoffman
Dr. Hartnett highlights new approaches to ROP care and the changing ethical, clinical, and technological landscape in a guest lecture.
Advertisement
Latest Updated Articles
FLORetina 2025: New horizons in research and risk management for ROPPublished: December 6th 2025 | Updated:
FLORetina 2025: EU-ROP Registry bridges borders for real-world insightPublished: December 7th 2025 | Updated:
Advertisement
Advertisement